Literature DB >> 17544080

Thyroid and parathyroid operations in veterans affairs and selected university medical centers: results of the patient safety in surgery study.

Bruce Lee Hall1, Mitzi Hirbe, Yan Yan, Shukri F Khuri, William G Henderson, Barton H Hamilton.   

Abstract

BACKGROUND: There is increasing interest in surgical outcomes. The Patient Safety in Surgery (PSS) Study database was examined about thyroid and parathyroid procedures to determine risk factors for adverse outcomes and outcomes rates. Relative outcomes performance for the Veterans Affairs (VA) and private-sector populations was compared after risk adjustment. STUDY
DESIGN: Preoperative, operative, and postoperative data were analyzed for 7,082 patients: 2,814 VA patients and 4,268 private sector patients. Prevalence of risk or process factors was described. Occurrence rates and unadjusted odds ratios (OR) for adverse outcomes were calculated. Stepwise multiple logistic regressions were performed to model the impact of various factors on outcomes and to calculate the adjusted OR for any adverse event for the VA population compared with the private sector.
RESULTS: Overall mortality rate was 0.35% and 0.60% in the VA and 0.19% in the private sector. Overall rate of any adverse outcomes was 2.90% and 4.48% in the VA and 1.97% in the private sector. Adjusted OR for thyroid versus parathyroid operation was 0.94 (95% CI, 0.67-1.31). Adjusted OR for operation in the VA versus private sector was 1.25 (95% CI, 0.87-1.78).
CONCLUSIONS: Overall rates of mortality and any morbidity were low and consistent with previous reports. Based on adjusted OR, there was no significant difference in outcomes for thyroid versus parathyroid operation. Similarly, there was no apparent significant difference in surgical outcomes between the VA and private-sector groups after risk adjustment.

Entities:  

Mesh:

Year:  2007        PMID: 17544080     DOI: 10.1016/j.jamcollsurg.2007.02.073

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  7 in total

Review 1.  Comparing VA and Non-VA Quality of Care: A Systematic Review.

Authors:  Claire O'Hanlon; Christina Huang; Elizabeth Sloss; Rebecca Anhang Price; Peter Hussey; Carrie Farmer; Courtney Gidengil
Journal:  J Gen Intern Med       Date:  2016-07-15       Impact factor: 5.128

2.  Safety of same-day thyroidectomy: meta-analysis and systematic review.

Authors:  Helmi Khadra; Salah Mohamed; Adam Hauch; John Carter; Tian Hu; Emad Kandil
Journal:  Gland Surg       Date:  2017-08

3.  Increased efficiency of endocrine procedures performed in an ambulatory operating room.

Authors:  Nicholas Clark; David F Schneider; Sara Vrabec; Philip S Bauer; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2013-05-09       Impact factor: 2.192

4.  Risk factors for readmission after lower extremity bypass in the American College of Surgeons National Surgery Quality Improvement Program.

Authors:  Jennifer Q Zhang; Thomas Curran; John C McCallum; Li Wang; Mark C Wyers; Allen D Hamdan; Raul J Guzman; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2014-01-31       Impact factor: 4.268

5.  Risk factors for postoperative complications in total thyroidectomy: A retrospective, risk-adjusted analysis from the National Surgical Quality Improvement Program.

Authors:  Lisa Caulley; Stephanie Johnson-Obaseki; Lindy Luo; Hedyeh Javidnia
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

Review 6.  Feasibility and Safety of Outpatient Thyroidectomy: A Narrative Scoping Review.

Authors:  Justine Philteos; Elif Baran; Christopher W Noel; Jesse D Pasternak; Kevin M Higgins; Jeremy L Freeman; Albino Chiodo; Antoine Eskander
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-28       Impact factor: 5.555

7.  Factors Associated With Neck Hematoma After Thyroidectomy: A Retrospective Analysis Using a Japanese Inpatient Database.

Authors:  Sayaka Suzuki; Hideo Yasunaga; Hiroki Matsui; Kiyohide Fushimi; Yuki Saito; Tatsuya Yamasoba
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.